Demo Sign up Log In

Urogen Pharma Ltd (URGN)

Cash Conversion Ratio

2.30×

Quarterly · Period ending: Jun 30, 2026

URGN Cash Conversion Ratio

Latest reported2.30×period endingJun 30, 2026

Latest reported2.30×period endingJun 30, 2026

URGN Quarterly Cash Conversion Ratio (1.08× → 2.30×)

Latest values, visible window

High-resolution chart · PNG

URGN cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Jun 30, 2026	2.3041×
Mar 31, 2026	1.9246×
Dec 31, 2025	1.4543×
Sep 30, 2025	1.2702×
Jun 30, 2025	0.8003×
Mar 31, 2025	0.9595×
Dec 31, 2024	0.3661×
Sep 30, 2024	1.1726×
Jun 30, 2024	0.7135×
Mar 31, 2024	0.9829×
Dec 31, 2023	0.5039×
Sep 30, 2023	0.7952×
Jun 30, 2023	0.8406×
Mar 31, 2023	0.8549×
Dec 31, 2022	0.7539×
Sep 30, 2022	0.6522×
Jun 30, 2022	0.909×
Mar 31, 2022	0.846×
Dec 31, 2021	0.7125×
Sep 30, 2021	0.618×
Jun 30, 2021	0.7251×
Mar 31, 2021	1.0676×
Dec 31, 2020	0.7015×
Sep 30, 2020	0.8933×
Jun 30, 2020	0.7725×
Jun 30, 2019	0.6493×
Sep 30, 2018	0.4681×
Jun 30, 2018	0.4593×
Mar 31, 2018	0.7246×
Dec 31, 2017	0.6074×
Sep 30, 2017	-8.6477×
Mar 31, 2017	0.8262×
Dec 31, 2016	1.0754×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.